Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from MarketBeat

Cavco Industries Q4 Earnings Call Highlights

Cavco Industries (NASDAQ:CVCO) reported higher fourth-quarter revenue and profit compared with the prior year, while management said orders strengthened late in the period and backlogs improved heading into the new fiscal year. On the company’s fiscal fourth-quarter earnings call, President and CEO

MarketBeat

Global Ship Lease Q1 Earnings Call Highlights

Global Ship Lease (NYSE:GSL) executives said the container ship lessor entered 2026 with full charter coverage for the year, a strengthened balance sheet and more than $2 billion in contracted revenue, while warning that escalating geopolitical disruptions are reshaping global trade routes and vesse

MarketBeat

Bicara Therapeutics ASCO Data Bolster Ficerafusp Alfa in Head and Neck Cancer

Bicara Therapeutics (NASDAQ:BCAX) said new data to be presented at the 2026 American Society of Clinical Oncology annual meeting support the clinical profile of ficerafusp alfa, also referred to by the company as Ficara, in first-line recurrent or metastatic HPV-negative head and neck cancer. On an

MarketBeat

From analysis to the latest developments in health,
read the most diverse news in one place.

Frontline Q1 Earnings Call Highlights

Frontline (NYSE:FRO) reported what Chief Executive Officer Lars Barstad called the company’s most profitable quarter since 2004, as tanker markets were reshaped by the effective closure of the Strait of Hormuz and shifting global oil trade patterns. Speaking on the company’s first-quarter 2026 earn

MarketBeat

Flowers Foods Q1 Earnings Call Highlights

Flowers Foods (NYSE:FLO) said it delivered first-quarter bottom-line results ahead of expectations despite softer sales trends and continued pressure in the traditional bread category, as management pointed to brand investment, cost controls and balance sheet priorities as key themes for the rest of

MarketBeat

Imperial Petroleum Q1 Earnings Call Highlights

Imperial Petroleum (NASDAQ:IMPP) reported sharply higher first-quarter 2026 results, with management saying the company benefited from a larger fleet and a surge in tanker rates tied to geopolitical disruptions in the Middle East. Chief Executive Officer Harry Vafias said the quarter marked the com

MarketBeat

CAVA Group’s Stock Looks Delicious After Strong Earnings

CAVA stock surged after the company posted strong Q1 earnings, raised guidance, and delivered impressive same-store sales growth despite valuation concerns

MarketBeat

Read news from The Economist, FT, and more,
with one subscription

ProSiebenSat.1 Media AGM Puts Entertainment Pivot, Cost Cuts in Spotlight

ProSiebenSat.1 Media (ETR:PSM) used its annual general meeting to outline a sharper focus on entertainment, tighter financial discipline and continued cost reductions following a year marked by weak advertising markets, portfolio disposals and a change in control after MFE became majority shareholde

MarketBeat

CAE Q4 Earnings Call Highlights

CAE (NYSE:CAE) reported higher fourth-quarter and full-year revenue for fiscal 2026, but management said weaker civil aviation training conditions, disruption tied to the Middle East conflict and transformation-related costs weighed on profitability and will continue to affect the company’s near-ter

MarketBeat

BJ's Wholesale Club Q1 Earnings Call Highlights

BJ's Wholesale Club (NYSE:BJ) reported a solid start to fiscal 2026, with management pointing to membership gains, higher fuel volumes, digital adoption and new club openings as key drivers of first-quarter performance. Chairman and Chief Executive Officer Bob Eddy said the retailer’s results were

MarketBeat

Booz Allen Hamilton Q4 Earnings Call Highlights

Booz Allen Hamilton (NYSE:BAH) executives said the government technology contractor exited what Chief Executive Horacio Rozanski called its “most challenging year” as a public company with stronger profitability than expected, even as revenue declined because of weakness in its civil business. On t

MarketBeat

Lowe's Finds Support at $215 After Q1 Earnings Sell-Off

Lowe's stock is on track to rebound from its recent lows but it will take time for full price recovery. Catalysts include thawing housing markets.

MarketBeat

So-Young International Q1 Earnings Call Highlights

So-Young International (NASDAQ:SY) reported sharply higher first-quarter 2026 revenue, driven by rapid growth in its branded aesthetic center business, while management said the company is continuing to expand its clinic footprint and invest in standardized medical delivery. Total revenue rose 45.6

MarketBeat

Overextended, e.l.f. Beauty Is Primed to Rebound in Back Half

e.l.f. Beauty is setting up for a rebound with the stock near long-term lows and growth catalysts ahead. Analysts forecast 75% upside.

MarketBeat

Get all your
news in one place.

100's of premium titles.
One news app.

MarketBeat

Contineum Therapeutics Touts PIPE-791 IPF Focus as Pain Data Hint at Wider Potential

Contineum Therapeutics (NASDAQ:CTNM) President and Chief Executive Officer Carmine Stengone said the company remains focused on advancing PIPE-791 in idiopathic pulmonary fibrosis, while recent exploratory pain data may point to additional clinical opportunities for the LPA1 receptor antagonist. Sp

MarketBeat

CorMedix Eyes REZZAYO Expansion as DefenCath Reimbursement Shift Looms

CorMedix (NASDAQ:CRMD) CEO Joe said the company is preparing for several potential commercial and regulatory catalysts across its infectious disease and dialysis-related portfolio, including a possible expansion of REZZAYO into fungal infection prophylaxis and continued work to sustain DefenCath uti

MarketBeat

Helical H2 Earnings Call Highlights

Helical (LON:HLCL) reported a year of operational progress and improved earnings as the London-focused developer advanced several major projects, completed the sale of 100 New Bridge Street and announced a larger return of capital to shareholders. Chief Executive Matthew Bonning-Snook said the comp

MarketBeat

Corbus Pharmaceuticals Teases Key ASCO Cancer Data, Late-Summer Obesity Readout

Corbus Pharmaceuticals (NASDAQ:CRBP) Chief Executive Officer Yuval Cohen said investors should expect more mature clinical updates for CRB-701 at the upcoming ASCO meeting, including the first durability and progression-free survival data for the company’s highlighted cervical and head and neck canc

Get all your
news in one place.

100's of premium titles.
One news app.

MarketBeat

Coinbase Global Says New Crypto Rules Could Unleash Its ‘Everything Exchange’

Coinbase Global (NASDAQ:COIN) executives said the company is preparing for a broader expansion of crypto trading, stablecoin payments, derivatives, tokenized assets and AI-driven commerce, with pending U.S. market structure legislation viewed as a potential catalyst. Speaking at JPMorgan’s TMC Conf

MarketBeat

Connect Biopharma Touts Rademikibart’s Edge as SEABREEZE Data Looms in 2026

Connect Biopharma (NASDAQ:CNTB) Chief Executive Officer Barry Quart said the company’s rademikibart program continues to show a differentiated clinical and mechanistic profile as the company awaits mid-2026 data from its SEABREEZE study. Speaking during a fireside chat with H.C. Wainwright analyst

MarketBeat

C.H. Robinson Worldwide Sees Freight Broker Shakeout, Downplays Insurance Hit

C.H. Robinson Worldwide (NASDAQ:CHRW) executives said the freight brokerage industry could see accelerated consolidation following the Montgomery ruling, while emphasizing that the company does not expect a material financial hit from higher insurance costs. Speaking at the Wolfe Research conferenc

MarketBeat

Zoom Communications Q1 Earnings Call Highlights

Zoom Communications (NASDAQ:ZM) reported a stronger-than-expected start to fiscal 2027, with executives pointing to enterprise demand, artificial intelligence adoption and customer experience products as key contributors to the quarter’s performance. On the company’s first-quarter fiscal 2027 earni

MarketBeat

Black Diamond Therapeutics Lung Cancer Drug Shows 15.2-Month PFS in Phase 2 Study

Black Diamond Therapeutics (NASDAQ:BDTX) reported updated Phase 2 data for silevertinib in treatment-naive non-small cell lung cancer patients with EGFR Non-Classical Mutations, saying the investigational therapy produced a preliminary median progression-free survival of 15.2 months in the study coh

MarketBeat

Copart Q3 Earnings Call Highlights

Copart (NASDAQ:CPRT) reported higher revenue and profit for its fiscal third quarter of 2026, even as insurance unit volumes declined amid softer claims activity and shifting consumer insurance behavior. Chief Executive Officer Jeff Liaw said global insurance unit sales fell 2.7% in the quarter, or

MarketBeat

Webull Q1 Earnings Call Highlights

Webull (NASDAQ:BULL) reported first-quarter revenue growth of 36% year over year, as higher trading activity across equities, options and newer asset classes helped offset a more volatile market backdrop and heavier marketing spending. The digital brokerage generated total revenue of $159.9 million

1 … 20 21 22 23

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Artificial Intelligence

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.